MR
Merck & Co.
MRK · NYSE
$150.32 -1.33% (-$2.02)
1M +16.92%
Market Cap $376.2B
P/E Ratio 118.56x
Div. Yield 2.21%
ROE 6.60%
Bulios Fair Price
$149.29
0.7% downside
Trenutna cena
$150.32
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica MRK trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
21 /100
Expensive EV/EBITDA 30.57x
P/S 5.67x
P/B 8.97x
Growth
34 /100
Stable Rev. growth 3.08%
FCF growth 5.63%
Book val. growth 4.58%
Profitability
78 /100
Strong Net margin 4.78%
Op. margin 16.65%
FCF margin 24.19%
Quality
31 /100
Poor ROE 6.60%
ROA 2.44%
Asset turnover 0.51x
Debt
46 /100
Moderate Current ratio 1.32x
Int. coverage 5.71x
Net debt/EBITDA 3.40x
Stability
47 /100
Moderate Rev. volatility 3.15%
EPS volatility 2,748.15%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MRK
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert Davis
Employees
74,000
Headquarters
Rahway
Prihajajoči dogodki
15 SEP.
Ex-Dividend
Ex-dividend date
07 OKT.
Dividend Payment
Datum plačila
29 OKT.
Earnings
Upcoming earnings report